Hidradenitis Suppurativa
Longitudinal, multi-source, curated datasets, offering rapid access to deep clinical data, insights and outcomes in Hidradenitis Suppurativa (HS).
Research-Grade RWD in Hidradenitis Suppurativa
Unmet Need
Studies continue to show the link between skin conditions and mental health, and with 1 in 4 Americans impacted by a skin disease, combined with the increasing mental health epidemic, it’s critical to uncover and introduce solutions that will ultimately improve health outcomes. What’s more, it’s common for patients with HS, which is associated with multiple somatic and psychiatric comorbidities – including obesity, anxiety, depression and Polycystic Ovary Syndrome – to live with the disease for 12 years or longer before getting diagnosed, as the condition is often misdiagnosed.
41,000*
HS patients prospectively followed by specialists with mean follow-up 7.7 years
*Counts complete through Q2 2024
245,000*
HS patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes
A Closer Look at the HS Network
225,000 Hidradenitis Suppurativa patients in the OM1 Real-World Data Cloud
Immunology Resources
eBook
Publications
- Elyze M, Stevens L, Weiss S. Management of HS by Dermatologists and Rheumatologists: Findings from a Large Contemporaneous Real-World Longitudinal Database. AAD Annual Meeting, March 2023, New Orleans LA.
- Stevens L, Kumparatana P, Elyze M, Clemens R, Weiss S. Characterization of Patients with Co-morbid Dermatological and Mental Health Conditions. AAD Annual Meeting, March 2023, New Orleans LA.
Award-Winning Research Team
Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.